Literature DB >> 22306621

Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase.

Hongying Duan1, Akira Takagi, Hidekazu Kayano, Isamu Koyama, Christophe Morisseau, Bruce D Hammock, Toshitaka Akatsuka.   

Abstract

In a previous study, we developed five kinds of monoclonal antibodies against different portions of human mEH: three, anti-N-terminal; one, anti-C-terminal; one, anti-conformational epitope. Using them, we stained the intact and the permeabilized human cells of various kinds and performed flow cytometric analysis. Primary hepatocytes and peripheral blood mononuclear cells (PBMC) showed remarkable differences. On the surface, hepatocytes exhibited 4 out of 5 epitopes whereas PBMC did not show any of the epitopes. mEH was detected inside both cell types, but the most prominent expression was observed for the conformational epitope in the hepatocytes and the two N-terminal epitopes in PBMC. These differences were also observed between hepatocyte-derived cell lines and mononuclear cell-derived cell lines. In addition, among each group, there were several differences which may be related to the cultivation, the degree of differentiation, or the original cell subsets. We also noted that two glioblastoma cell lines reveal marked expression of the conformational epitope on the surface which seemed to correlate with the brain tumor-associated antigen reported elsewhere. Several cell lines also underwent selective permeabilization before flow cytometric analysis, and we noticed that the topological orientation of mEH on the ER membrane in those cells was in accordance with the previous report. However, the orientation on the cell surface was inconsistent with the report and had a great variation between the cells. These findings show the multiple mode of expression of mEH which may be possibly related to the multiple roles that mEH plays in different cells. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306621      PMCID: PMC3319120          DOI: 10.1016/j.taap.2012.01.021

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  23 in total

1.  Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells.

Authors:  B C Krovat; J H Tracy; C J Omiecinski
Journal:  Toxicol Sci       Date:  2000-06       Impact factor: 4.849

2.  Identification of epoxide hydrase as the preneoplastic antigen in rat liver hyperplastic nodules.

Authors:  W Levin; A Y Lu; P E Thomas; D Ryan; D E Kizer; M J Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Differential permeabilization of membranes by saponin treatment of isolated rat hepatocytes. Release of secretory proteins.

Authors:  M Wassler; I Jonasson; R Persson; E Fries
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

4.  Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopin-treated male DBA/2 mice.

Authors:  F Waechter; P Bentley; F Bieri; S Muakkassah-Kelly; W Stäubli; M Villermain
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

5.  Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice.

Authors:  A M Eriksson; M A Zetterqvist; B Lundgren; K Andersson; B Beije; J W DePierre
Journal:  Eur J Biochem       Date:  1991-06-01

6.  Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase.

Authors:  R Kessler; M F Hamou; M Albertoni; N de Tribolet; M Arand; E G Van Meir
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  Human glioma-associated antigens detected by monoclonal antibodies.

Authors:  J F Schnegg; A C Diserens; S Carrel; R S Accolla; N de Tribolet
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

8.  A methodology for the analysis of the preneoplastic antigen.

Authors:  B D Hammock; D N Loury; D E Moody; B Ruebner; R Baselt; K M Milam; P Volberding; A Ketterman; R Talcott
Journal:  Carcinogenesis       Date:  1984-11       Impact factor: 4.944

9.  Cell surface expression and bile acid transport function of one topological form of m-epoxide hydrolase.

Authors:  Patricia von Dippe; Qin-shi Zhu; Daniel Levy
Journal:  Biochem Biophys Res Commun       Date:  2003-10-03       Impact factor: 3.575

10.  Measurement and characterization of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leukocytes from human blood.

Authors:  J Seidegård; J W DePierre; R W Pero
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

View more
  3 in total

1.  A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Kasem Nithipatikom; Michael P Endsley; Adam W Pfeiffer; John R Falck; William B Campbell
Journal:  J Lipid Res       Date:  2014-06-23       Impact factor: 5.922

Review 2.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

3.  Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma.

Authors:  Satoyoshi Yamashita; Akira Kato; Toshitaka Akatsuka; Takashi Sawada; Tomohide Asai; Noriyuki Koyama; Kiwamu Okita
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.